One current explanation for resistance to TNF blockade therapy is that in subsets of RA patients synovitis is driven by distinct pathogenic mechanisms; additionally, these different mechanisms can emerge when TNF activity is blocked, which can explain acquired resistance to TNF blockade. This evidence concerns the gene TNF and rheumatoid arthritis.